Pharma Deals
-
{
- All
- News
- Videos
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
Indian Pharmaceutical Body Signs 3 Memorandums To Strengthen Drug Safety And Quality Standards
The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and HLL Infra Tech Services to strengthen drug safety, quality assurance and pharmacovigilance.
-
Textiles, Gems, Pharma: Sectors To Be Impacted By India-US Trade Deal
Sectors such as gems and jewelry, textiles, fisheries, and chemicals are likely to react positively in the market following the India-US trade deal.
-
$100 Million Boost For India-Afghanistan Trade Marks Setback for Pakistan
In a significant development that signals a new phase of India-Afghanistan economic cooperation and a blow to Pakistan's regional trade influence, leading pharmaceutical companies from India and Afghanistan have signed a $100 million MoU.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Inside Naman Xana In Mumbai, Where Pharma Royalty Leena Gandhi Tewari Bought Ultra-Luxury Flats For Rs 703 Crore
Leena Gandhi Tewari's purchase of these two sea-facing duplexes sets a new benchmark in India's luxury real-estate market
-
Chandrababu Naidu Stresses Workplace Safety After Andhra Pharma Firm Blast
Workplace safety - particularly in 'red category' industries, or those that deal with hazardous materials and have a pollution index over 60 - must go hand-in-hand with investment in the state, Andhra Pradesh Chief Minister N Chandrababu Naidu said.
-
Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
-
Wockhardt To Manufacture, Supply Sputnik Covid Vaccines
Indian pharma major Wockhardt announced today that the company has signed a deal with Dubai's Enso Healthcare to make and supply doses of Russia's Sputnik V / Sputnik Light vaccine against COVID-19.
-
Wockhardt Makes Deal For Mystery Vaccine, Announcement In 2 Weeks
Indian pharma major Wockhardt is set to announce a major production deal for an undisclosed vaccine. The formal announcement is due in two weeks and the production of the vaccine will begin in October.
-
Moderna Declined Request For Sending Vaccines Directly To State: Punjab
Punjab has said that the US pharma major Moderna had refused to directly supply its Covid vaccine to the state as it only deals with the central government.
-
Thailand To Make, Supply UK Pharma Firm AstraZeneca's COVID-19 Vaccine
Thailand has agreed to manufacture and supply AstraZeneca Plc's experimental COVID-19 vaccine in the southeast Asian country and other nations in the region, the British and Thai governments said on Monday.
-
Bharat Biotech Partners With US University For Single-Dose Covid Vaccine
Hyderabad-based pharma firm Bharat Biotech, which is developing coronavirus vaccine COVAXIN, has signed a licensing deal with Washington University School of Medicine in Missouri's St. Louis, United States, for a "novel chimp-adenovirus", single dose intranasal vaccine for COVID-19. Bharat Biotech would be allowed to distribute the vaccine in all m...
-
In New Vaccine Deal, A Step Forward For India And Bangladesh
As the race for a COVID-19 vaccine intensifies, Bangladesh's leading pharma company Beximco has announced it will be investing in Adar Poonawalla's Serum India Limited (SIL) for development of the vaccine. The size of the investment has not been disclosed but will depend on SIL's priority supply commitment to Beximco Pharma Ltd (BPL).
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
Indian Pharmaceutical Body Signs 3 Memorandums To Strengthen Drug Safety And Quality Standards
The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and HLL Infra Tech Services to strengthen drug safety, quality assurance and pharmacovigilance.
-
Textiles, Gems, Pharma: Sectors To Be Impacted By India-US Trade Deal
Sectors such as gems and jewelry, textiles, fisheries, and chemicals are likely to react positively in the market following the India-US trade deal.
-
$100 Million Boost For India-Afghanistan Trade Marks Setback for Pakistan
In a significant development that signals a new phase of India-Afghanistan economic cooperation and a blow to Pakistan's regional trade influence, leading pharmaceutical companies from India and Afghanistan have signed a $100 million MoU.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Inside Naman Xana In Mumbai, Where Pharma Royalty Leena Gandhi Tewari Bought Ultra-Luxury Flats For Rs 703 Crore
Leena Gandhi Tewari's purchase of these two sea-facing duplexes sets a new benchmark in India's luxury real-estate market
-
Chandrababu Naidu Stresses Workplace Safety After Andhra Pharma Firm Blast
Workplace safety - particularly in 'red category' industries, or those that deal with hazardous materials and have a pollution index over 60 - must go hand-in-hand with investment in the state, Andhra Pradesh Chief Minister N Chandrababu Naidu said.
-
Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
-
Wockhardt To Manufacture, Supply Sputnik Covid Vaccines
Indian pharma major Wockhardt announced today that the company has signed a deal with Dubai's Enso Healthcare to make and supply doses of Russia's Sputnik V / Sputnik Light vaccine against COVID-19.
-
Wockhardt Makes Deal For Mystery Vaccine, Announcement In 2 Weeks
Indian pharma major Wockhardt is set to announce a major production deal for an undisclosed vaccine. The formal announcement is due in two weeks and the production of the vaccine will begin in October.
-
Moderna Declined Request For Sending Vaccines Directly To State: Punjab
Punjab has said that the US pharma major Moderna had refused to directly supply its Covid vaccine to the state as it only deals with the central government.
-
Thailand To Make, Supply UK Pharma Firm AstraZeneca's COVID-19 Vaccine
Thailand has agreed to manufacture and supply AstraZeneca Plc's experimental COVID-19 vaccine in the southeast Asian country and other nations in the region, the British and Thai governments said on Monday.
-
Bharat Biotech Partners With US University For Single-Dose Covid Vaccine
Hyderabad-based pharma firm Bharat Biotech, which is developing coronavirus vaccine COVAXIN, has signed a licensing deal with Washington University School of Medicine in Missouri's St. Louis, United States, for a "novel chimp-adenovirus", single dose intranasal vaccine for COVID-19. Bharat Biotech would be allowed to distribute the vaccine in all m...
-
In New Vaccine Deal, A Step Forward For India And Bangladesh
As the race for a COVID-19 vaccine intensifies, Bangladesh's leading pharma company Beximco has announced it will be investing in Adar Poonawalla's Serum India Limited (SIL) for development of the vaccine. The size of the investment has not been disclosed but will depend on SIL's priority supply commitment to Beximco Pharma Ltd (BPL).
